Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
M.D. Anderson Cancer Center
Pfizer
Pheon Therapeutics
National Cancer Institute (NCI)
Takeda
Tempus AI
Sanofi
NRG Oncology
Black Diamond Therapeutics, Inc.
Elevation Oncology
Mirati Therapeutics Inc.
ABM Therapeutics Corporation
Inhibrx Biosciences, Inc
NantCell, Inc.
Washington University School of Medicine
Centre Hospitalier Henri Duffaut - Avignon
NKGen Biotech, Inc.
Fusion Pharmaceuticals Inc.
Rutgers, The State University of New Jersey
pharmaand GmbH
Fate Therapeutics
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Incyte Corporation
Montefiore Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Lumos Pharma
Pfizer
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Yale University
CureOne
National Institutes of Health Clinical Center (CC)
Helsinn Healthcare SA
Washington University School of Medicine
Cota Inc.
University Health Network, Toronto
Albert Einstein College of Medicine
Masonic Cancer Center, University of Minnesota
New York State Psychiatric Institute
Cornerstone Pharmaceuticals